from 0 05 J to 25 J for ventricular tachycardia and from 1 J to 25 J for ventricular fibrillation. The nine successful shocks of 1 J or less did not require sedation or general anaesthesia. High energy (25 J) endocardial shocks were unsuccessful in terminating arrhythmias in two patients, one with ventricular tachycardia and the other with both ventricular tachycardia and fibrillation. Minor unwanted effects of endocardial shocks occurred in five patients. These were acceleration of ventricular tachycardia in two patients and complications of pacing via the special lead in three others: failure of sensing occurred in all three and one patient also had a transient rise in pacing threshold. A postmortem examination in one patient who had received three unsuccessful high energy shocks revealed localised endocardial necrosis at the site of the distal electrode.
Transvenous cardioversion offers advantages over external cardioversion but at present practical difficulties limit its application to patients with recurrent ventricular arrhythmias that cannot readily be controlled by conventional methods.
Electrical treatment of life threatening ventricular arrhythmias occurring after myocardial infarction poses several problems; these include the need for repeated general anaesthetics, delays before cardioversion, and superficial bums. Nevertheless The cardioverter defibrillator used in this study was a purpose built manually operated device (Medtronic 5350, Medtronic Inc., Minneapolis, USA) that delivers a truncated exponential waveform. The waveform is described in terms of the relation of the voltage of the trailing edge to the leading edge. This is called "tilt" (fig 1) . The percentage tilt is the percentage decrease between the leading edge and the trailing edge voltage. Three different tilts were available, namely, 27%, 63%, or 82%.
The shocks used throughout the study had 63% tilt 15.0J 63 1. 6ms
16.8J 82 .
10 ms *For discharge over a 100 Q load 
Results
In 14 of the 17 patients the pacing lead was positioned successfully and remained stable. Of these 14, 10 had further tachycardia that required cardioversion; all were successfully treated at least once. Three had ventricular fibrillation, six had ventricular tachycardia, and one patient had both. Tachycardia was terminated on 42 separate occasions. Figure 2 shows an example of successful transvenous cardioversion.
Four patients in whom the lead remained stable did not receive endocardial shocks. Three settled on antiarrhythmic treatment once the lead was in position, while one patient developed self-terminating multiform ventricular tachycardia that was suppressed successfully by ventricular overdrive pacing via the special lead. In the three remaining patients difficulties were experienced with lead placement or subsequent lead stability: in one, ventricular fibrillation was triggered repeatedly on crossing the tricuspid valve; in the second, instability prevented initial lead placement; in the third, the procedure was abandoned because of repeated lead displacement.
The energy levels associated with successful cardioversion varied from 0 05 J to 25 J (median 10 J). Ventricular tachycardia was terminated by synchronised shocks of 0-05 J-25 J (median 2 J) and ventricular fibrillation by asynchronous shocks ranging from 1 J to 25 J (median 10 J). The difference between the mean energy levels required for cardioversion of tachycardia and fibrillation did not reach statistical significance. Perception of discomfort caused by transvenous cardioversion varied, but the nine successful shocks of 1 J or less did not cause undue discomfort and required neither sedation nor general anaesthesia.
Transvenous cardioversion failed to terminate some episodes of ventricular arrhythmias in two patients. High energy (25 J) endocardial shocks were unsuccessful in terminating ventricular tachycardia in one patient and ventricular tachycardia or fibrillation in another; sinus rhythm was restored in each case by external countershock. In both of these patients further arrhythmias did respond to transvenous cardioversion. Subsequently these two patients died of intractable cardiac failure. Necropsy in one who had received three unsuccessful high energy shocks revealed an area of myocardial necrosis to a depth of 0-5 cm around the distal tip of the lead.
Unwanted effects of transvenous cardioversion occurred in five patients. Two of them had acceleration of ventricular tachycardia or provocation of ventricular fibrillation in response to synchronised low energy shocks (fig 3) . Reversion to sinus rhythm was achieved by higher energy endocardial shock and by external countershock. The unwanted effects of transvenous cardioversion in the three other patients were related to pacing after endocardial shock. Although pacing was achieved satisfactorily in most patients who required it, inappropriate pacing due to failure of sensing after endocardial shock occurred in each of these three patients. In addition, one had a transient rise in pacing threshold from 07V to 2-4V. 
